Cardiac failure acute
Not yet recruitingStudy on AP-01 for Patients with Acute Heart Failure (NYHA Class III or Higher)
- Disease:Cardiac failure acute
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Ananda Pharma GmbH
Rare diseases
Investigational molecules
Locations

Karl-Liebknecht-Strasse 94, Babelsberg Nord, 14482 Potsdam, Germany
Ananda Pharma GmbH’s clinical research activity is centred on acute heart failure, with a clear focus on cardiac conditions requiring urgent therapeutic attention. Its trial portfolio reflects interest in the clinical burden of heart failure and the management of patients with rapidly worsening cardiac function.
The sponsor’s research in this area is aligned with the evaluation of clinically meaningful cardiac outcomes and the broader treatment landscape for severe cardiovascular disease.
Ananda Pharma GmbH runs clinical trials in conditions such as Cardiac failure acute, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.